Financhill
Back

Edwards Lifesciences Quote, Financials, Valuation and Earnings

Take advantage of the biggest IPO in history

Click here to see more
Sell
28

EW
Edwards Lifesciences

Last Price:
76.35
Seasonality Move:
-0.09%

7 Day Trial

ALL ACCESS PASS

$ 7

Is Elon Musk right about AI?

Learn all about it here.

Edwards Lifesciences Price Quote

$76.35
-0.03 (-0.16%)
(Updated: September 2, 2023 at 6:10 AM ET)

Edwards Lifesciences Key Stats

Sell
28
Edwards Lifesciences (EW) is a Sell

Day range:
$75.85 - $77.20
52-week range:
$67.13 - $98.35
Dividend yield:
0%
P/E ratio:
31.30
P/S ratio:
8.31
P/B ratio:
7.28%

Volume:
2.4M
Avg. volume:
3.6M
1-year change:
-15.25%
Market cap:
$46.4B
Revenue:
$5.4B
EPS:
$2.26

How Much Does Edwards Lifesciences Make?

Is Edwards Lifesciences Growing As A Company?

  • What Is Edwards Lifesciences's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.11%
  • What Is Edwards Lifesciences's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is -0.23%

Edwards Lifesciences Stock Price Performance

What Is Edwards Lifesciences 52-Week High & Low?

Edwards Lifesciences Price To Free Cash Flow

Is It Risky To Buy Edwards Lifesciences?

Is Edwards Lifesciences Cash Flow Positive?

  • What Is EW Cash Flow From Operations?
    Cash flow from operations (TTM) is $940.4M
  • What Is Edwards Lifesciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$1.1B
  • What Is Edwards Lifesciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$36.1M

Edwards Lifesciences Return On Invested Capital

  • Is Management Doing A Good Job?
    EW return on invested capital is 20.77%
  • What Is Edwards Lifesciences Return On Assets?
    ROA measures how assets are converting to revenues and is 16.15%
  • What Is EW Return On Equity?
    ROE is a measure of profitability and is 22.91%

Edwards Lifesciences Earnings Date & Stock Price

Edwards Lifesciences Competitors

Edwards Lifesciences Dividend Yield

Data Unavailable

Edwards Lifesciences Analyst Estimates

YoY Growth Past Surprise
EPS: -23.08% 1.89%
Revenue: 11.38% 1.67%

Analyst Recommendations

Buy Recommendations: 10
Hold Recommendations: 14
Sell Recommendations: 0
Price Target: 96.09
Upside from Last Price: 25.8%

Major Shareholders

  • How many EW shares are owned by institutional investors?
    761.3M EW shares are owned by institutional investors
  • How many EW shares are owned by insiders?
    1.7M EW shares are owned by insiders